Beyond molecules and microbes: biopharma's responsibility to racial justice in and outside its own walls

The killing of George Floyd has made it clear that life sciences leaders cannot focus exclusively on molecules or microbes, that their missions include helping to heal social as well as physical pathologies. The uncomfortable truth is that the financial and economic resources devoted to discovering and developing medicines come with responsibilities -- to help combat racism, reduce health disparities and reinvigorate civil societies.

For most, the responsibility is obvious; the urge to speak and act is spontaneous and authentic. Others are learning from their colleagues, employees, customers and families that complacency isn’t an option. ...